Glycyltyrosine

Identification

Summary

Glycyltyrosine is an ingredient in amino acid solutions for parenteral nutrition.

Generic Name

Glycyltyrosine

DrugBank Accession Number

DB15991

Background

Not Available

Type

Small Molecule

Groups

Experimental

Structure

3D

Download

MOLSDF3D-SDFPDBSMILESInChI

Similar Structures

Structure for Glycyltyrosine (DB15991)

×

Close

Weight

Average: 238.243
Monoisotopic: 238.095356939

Chemical Formula

C₁₁H₁₄N₂O₄

Synonyms

Not Available

External IDs

• 211-525-1
• NSC-83260

Poor quality drug data slowing you down?

Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.

Download eBook

Poor quality drug data slowing you down?

Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">

Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

Not Available

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Product Ingredients

Ingredient	UNII	CAS	InChI Key
Glycyltyrosine dihydrate	269373P3AW	39630-46-1	VELZBUAWAUZDLF-WWPIYYJJSA-N

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
Amino - Mel "nephro" - Infusionsflasche	Glycyltyrosine (3.16 g/L) + Acetylcysteine (0.54 g/L) + Alanine (6.2 g/L) + Arginine (8.2 g/L) + Glycine (5.31 g/L) + Histidine (9.8 g/L) + Isoleucine (5.8 g/L) + Leucine (12.8 g/L) + Lysine acetate (16.93 g/L) + Methionine (2 g/L) + Phenylalanine (3.5 g/L) + Proline (3 g/L) + Serine (7.6 g/L) + Threonine (8.2 g/L) + Tryptophan (3 g/L) + Tyrosine (0.6 g/L) + Valine (8.7 g/L)	Solution	Intravenous	Fresenius Kabi Austria Gmb H	1991-03-05	Not applicable
GLAMIN SOLUTION FOR INFUSION	Glycyltyrosine (3.45 g/1000ml) + Alanine (16 g/1000ml) + Arginine (11.3 g/1000ml) + Aspartic acid (3.4 g/1000ml) + Glutamic acid (5.6 g/1000ml) + Glycylglutamine (30.27 g/1000ml) + Histidine (6.8 g/1000ml) + Isoleucine (5.6 g/1000ml) + Leucine (7.9 g/1000ml) + Lysine acetate (12.7 g/1000ml) + Methionine (5.6 g/1000ml) + Phenylalanine (5.85 g/1000ml) + Proline (6.8 g/1000ml) + Serine (4.5 g/1000ml) + Threonine (5.6 g/1000ml) + Tryptophan (1.9 g/1000ml) + Valine (7.3 g/1000ml)	Injection	Intravenous	FRESENIUS KABI (SINGAPORE) PTE LTD	1998-07-27	Not applicable
Glavamin Infusionslösung	Glycyltyrosine (3.45 g/l) + Alanine (16 g/l) + Arginine (11.3 g/l) + Aspartic acid (3.4 g/l) + Glutamic acid (5.6 g/l) + Glycylglutamine (30.27 g/l) + Histidine (6.8 g/l) + Isoleucine (5.6 g/l) + Leucine (7.9 g/l) + Lysine acetate (12.7 g/l) + Methionine (5.6 g/l) + Phenylalanine (5.85 g/l) + Proline (6.8 g/l) + Serine (4.5 g/l) + Threonine (5.6 g/l) + Tryptophan (1.9 g/l) + Valine (7.3 g/l)	Solution	Parenteral	Fresenius Kabi Austria Gmb H	1996-03-29	Not applicable
Trimix MOF Emulsion zur Infusion	Glycyltyrosine dihydrate (1.725 g/1000mL) + Alanine (8 g/1000mL) + Arginine (5.65 g/1000mL) + Aspartic acid (1.7 g/1000mL) + D-glucose monohydrate (110 g/1000mL) + Fish oil (7.5 g/1000mL) + Glutamic acid (2.8 g/1000mL) + Glycylglutamine monohydrate (15.135 g/1000mL) + Histidine (3.4 g/1000mL) + Isoleucine (2.8 g/1000mL) + Leucine (3.95 g/1000mL) + Levocarnitine (1 g/1000mL) + Lysine acetate (6.35 g/1000mL) + Medium-chain triglycerides (15 g/1000mL) + Methionine (2.8 g/1000mL) + Olive oil (12.5 g/1000mL) + Phenylalanine (2.925 g/1000mL) + Proline (3.4 g/1000mL) + Serine (2.25 g/1000mL) + Soybean oil (15 g/1000mL) + Threonine (2.8 g/1000mL) + Tryptophan (0.95 g/1000mL) + Valine (3.65 g/1000mL)	Emulsion	Parenteral	Fresenius Kabi Austria Gmb H	2012-09-21	Not applicable
Trimix nephro Emulsion zur Infusion	Glycyltyrosine (1.58 g/700mL) + Acetylcysteine (0.27 g/700mL) + Alanine (3.1 g/700mL) + Arginine (4.1 g/700mL) + Dextrose, unspecified form (60 g/700mL) + Fish oil (3 g/700mL) + Glycine (2.65 g) + Histidine (4.9 g) + Isoleucine (2.9 g/700mL) + Leucine (6.4 g/700mL) + Levocarnitine (1 g/700mL) + Lysine acetate (8.46 g/700mL) + Medium-chain triglycerides (6 g/700mL) + Methionine (1 g/700mL) + Olive oil (5 g/700mL) + Phenylalanine (1.75 g/700mL) + Proline (1.5 g/700mL) + Serine (3.8 g) + Soybean oil (6 g) + Threonine (4.1 g/700mL) + Tryptophan (1.5 g/700mL) + Tyrosine (0.3 g/700mL) + Valine (4.35 g/700mL)	Emulsion	Parenteral	Fresenius Kabi Austria Gmb H	2012-09-21	Not applicable

Categories

Drug Categories

• Amino Acids, Peptides, and Proteins
• Oligopeptides
• Peptides

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

A226496H4O

CAS number

658-79-7

InChI Key

XBGGUPMXALFZOT-VIFPVBQESA-N

InChI

InChI=1S/C11H14N2O4/c12-6-10(15)13-9(11(16)17)5-7-1-3-8(14)4-2-7/h1-4,9,14H,5-6,12H2,(H,13,15)(H,16,17)/t9-/m0/s1

IUPAC Name

(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanoic acid

SMILES

NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O

References

General References

1. BASG: Glavamin (Amino Acids) Intravenous Solution [Link]

External Links

Human Metabolome Database

HMDB0028853

ChemSpider

83798

BindingDB

50188508

ChEBI

73517

ChEMBL

CHEMBL53400

ZINC

ZINC000001730678

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">

Phase	Status	Purpose	Conditions	Count

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Solution	Intravenous
Injection	Intravenous	16 g/1000ml
Solution	Parenteral
Emulsion	Parenteral

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

Predicted Properties

Property	Value	Source
Water Solubility	1.84 mg/mL	ALOGPS
logP	-2.5	ALOGPS
logP	-2.6	Chemaxon
logS	-2.1	ALOGPS
pKa (Strongest Acidic)	3.4	Chemaxon
pKa (Strongest Basic)	8.12	Chemaxon
Physiological Charge	0	Chemaxon
Hydrogen Acceptor Count	5	Chemaxon
Hydrogen Donor Count	4	Chemaxon
Polar Surface Area	112.65 Å2	Chemaxon
Rotatable Bond Count	5	Chemaxon
Refractivity	59.9 m3·mol-1	Chemaxon
Polarizability	23.06 Å3	Chemaxon
Number of Rings	1	Chemaxon
Bioavailability	1	Chemaxon
Rule of Five	Yes	Chemaxon
Ghose Filter	No	Chemaxon
Veber's Rule	No	Chemaxon
MDDR-like Rule	No	Chemaxon

Predicted ADMET Features

Not Available

Spectra

Mass Spec (NIST)

Not Available

Spectra

Spectrum	Spectrum Type	Splash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)	Predicted LC-MS/MS	splash10-001r-0910000000-488a758300ea6bc97b78
Predicted MS/MS Spectrum - 10V, Negative (Annotated)	Predicted LC-MS/MS	splash10-03gr-4910000000-e793bbe520aa4f3caf5e
Predicted MS/MS Spectrum - 20V, Positive (Annotated)	Predicted LC-MS/MS	splash10-06si-0900000000-307a8a425322f7949dd9
Predicted MS/MS Spectrum - 20V, Negative (Annotated)	Predicted LC-MS/MS	splash10-0230-6900000000-6be1169ee2af55cf82de
Predicted MS/MS Spectrum - 40V, Positive (Annotated)	Predicted LC-MS/MS	splash10-0ab9-4900000000-c8501fa42cd6cd206fbc
Predicted MS/MS Spectrum - 40V, Negative (Annotated)	Predicted LC-MS/MS	splash10-01qc-4900000000-5dbf0dfddc6df7014ad5
Predicted 1H NMR Spectrum	1D NMR	Not Applicable
Predicted 13C NMR Spectrum	1D NMR	Not Applicable

Chromatographic Properties

Collision Cross Sections (CCS)

Adduct	CCS Value (Å2)	Source type	Source
[M-H]-	163.9423724	predicted	DarkChem Lite v0.1.0
[M-H]-	151.59637	predicted	DeepCCS 1.0 (2019)
[M+H]+	164.7623724	predicted	DarkChem Lite v0.1.0
[M+H]+	153.95439	predicted	DeepCCS 1.0 (2019)
[M+Na]+	164.7163724	predicted	DarkChem Lite v0.1.0
[M+Na]+	160.04759	predicted	DeepCCS 1.0 (2019)

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at December 10, 2020 17:10 / Updated at May 05, 2021 20:32